Form 8-K - Current report:
SEC Accession No. 0001640334-16-001522
Filing Date
2016-08-12
Accepted
2016-08-11 21:17:34
Documents
17
Period of Report
2016-08-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nmus_8k.htm 8-K 11865
2 SETTLEMENT AND RELEASE OF CLAIMS nmus_ex991.htm EX-99.1 7822
3 nmus_ex101img1.jpg GRAPHIC 135872
4 nmus_ex101img10.jpg GRAPHIC 34430
5 nmus_ex101img11.jpg GRAPHIC 20190
6 nmus_ex101img12.jpg GRAPHIC 46318
7 nmus_ex101img13.jpg GRAPHIC 20081
8 nmus_ex101img14.jpg GRAPHIC 114164
9 nmus_ex101img15.jpg GRAPHIC 64151
10 nmus_ex101img2.jpg GRAPHIC 147661
11 nmus_ex101img3.jpg GRAPHIC 152534
12 nmus_ex101img4.jpg GRAPHIC 161974
13 nmus_ex101img5.jpg GRAPHIC 146594
14 nmus_ex101img6.jpg GRAPHIC 108314
15 nmus_ex101img7.jpg GRAPHIC 141005
16 nmus_ex101img8.jpg GRAPHIC 104960
17 nmus_ex101img9.jpg GRAPHIC 19799
  Complete submission text file 0001640334-16-001522.txt   1975436
Mailing Address 650 TOWN CENTER DRIVE, SUITE 1770 COSTA MESA CA 92626
Business Address 650 TOWN CENTER DRIVE, SUITE 1770 COSTA MESA CA 92626 (949) 396-0330
Nemus Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 161826045
SIC: 2834 Pharmaceutical Preparations